Scientists have developed a powerful new artificial intelligence tool that could change the way we understand and treat brain diseases like Alzheimer’s and Parkinson’s. The tool, called RibbonFold, ...

In the fight against diseases like Alzheimer’s and Parkinson’s, scientists have long struggled to predict how certain ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

He has spent years studying neuroscience and neurodevelopment and described his company’s innovative technology as a game-changer in treating diseases like Hunter syndrome, Alzheimer’s and Parkinson’s ...

Susan Aaron was an active 74-year-old retiree with Alzheimer’s who was told she might experience extreme fatigue and terrible headaches if she tried a new drug from Eisai Co. that promised to ...

Sheffield (UK), Mar 29 (The Conversation) Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset ...

Lilly plans to seek re-examination of the CHMP's opinion. There are about 7 million people with Alzheimer's disease in Europe, according to the European Brain Council. "It is difficult to ...

Studies have linked low vitamin D with a higher risk of Alzheimer’s disease. However, it’s not clear whether vitamin D supplementation lowers Alzheimer’s risk. You can get vitamin D through ...

Short-term memory loss can be a sign of early-stage Alzheimer's disease. It can manifest as difficulty creating new memories or problems retrieving them. For example, someone with early Alzheimer's ...

Alzheimer’s disease is characterized by a host of recognizable cognitive symptoms, but many non-cognitive symptoms like changes in sleep, anxiety and depression can be early signs of the disease.